In breast cancer cells, overexpression of a synthetic miR-423-5p inhibits the expression of the Progesterone Receptor (PGR) gene, a prognostic marker of breast cancer [280], by reducing RNA polymerase II binding and enriching silent chromatin markers on PGR gene promoter [274]. The gene discussed is PGR; the disease is breast carcinoma.